发明名称 Stable iron oligosaccharide compound
摘要 The invention relates to an iron oligosaccharide compound with improved stability comprising a hydrogenated oligosaccharide in stable association with ferric oxyhydroxide, the content of dimer saccharide in said hydrogenated oligosaccharide being 2.9% by weight or less, based on the total weight of the hydrogenated oligosaccharide. In further aspects is provided a process for preparing said compound as well as the use of said compound for preparation of a composition for treatment of iron deficiency anaemia.
申请公布号 US8815301(B2) 申请公布日期 2014.08.26
申请号 US200913138669 申请日期 2009.03.25
申请人 Pharmacosmos Holding A/S 发明人 Andreasen Hans
分类号 A61K47/26;A61K47/36;A61K47/48;A61K33/26;A61K31/295;A61K31/721;C07H3/06;C08B37/02;C08B30/18 主分类号 A61K47/26
代理机构 Harness, Dickey & Pierce, P.L.C. 代理人 Harness, Dickey & Pierce, P.L.C.
主权项 1. An iron oligosaccharide compound comprising a hydrogenated oligosaccharide in stable association with ferric oxyhydroxide, the hydrogenated oligosaccharide having a weight average molecular weight (Mw) between 500 and 3,000 Daltons, wherein the content of dimer saccharide in said hydrogenated oligosaccharide is 2.9% by weight or less, based on the total weight of the hydrogenated oligosaccharide, wherein the hydrogenated oligosaccharide is hydrogenated dextran having a number average molecular weight (Mn) above 500 Daltons, 90% by weight of said dextran has molecular weights less than 3,500 Daltons, and the Mw of the 10% by the weight fraction of the dextran having the highest molecular weights is below 4,500 Daltons.
地址 Holbaek DK